Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline
Lyell Immunopharma has entered a definitive agreement to acquire ImmPACT Bio, a privately-owned clinical-stage biotechnology company specialising in chimeric antigen…
Deal News
-
-
Eximia Research acquires Integrated Clinical Trial Services
Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical Trial Services (ICTS).…
-
Myriad signs five partnerships to study MRD testing in breast cancer
Myriad Genetics has announced five research collaborations with health institutions to study the use of its Precise MRD test in…
-
Amid sales slump, Avantor sells off its clinical services business for $650m
In a bid to “strengthen its balance sheet”, Avantor has signed a definitive agreement to divest its clinical services business…
-
Vir Bio trims staff and pipeline to focus on Sanofi-licensed programmes
Vir Biotechnology has signed a licensing agreement with Sanofi for three clinical-stage masked T-cell engagers (TCE) for cancer treatment. The…
-
Otsuka snaps up Jnana with its phenylketonuria drug for $800m
Otsuka Pharmaceutical is looking to acquire US-based Jnana Therapeutics in a deal worth up to approximately $1.1bn. The Japanese company…
-
Lisata to use Haystack’s MRD tests for pancreatic cancer therapy trial
Lisata Therapeutics has partnered with Haystack Oncology, a Quest Diagnostics company, to use the latter’s minimal residual disease (MRD) test…
-
XyloCor taps SmartWise’s infusion device for gene therapy administration
XyloCor Therapeutics has signed a licencing agreement with SmartWise, a subunit of SmartCella Holding, to use the latter’s Extroducer infusion…
-
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio
Tectonic Therapeutic has completed a reverse merger with Avrobio and will begin trading on the Nasdaq global market as Tectonic…
-
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio…
